Publications

Search publications

01.10.25

Population Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

Oncology

MIDD

Pharmacometrics

CPT Pharmacometrics Syst Pharmacol. 2025 Oct 1.

Hong Y, Peigné S, Pan Y, Friberg Hietala S, Mc Laughlin AM, Tajima N, Uema D, Zebger-Gong H, Tang Z, Zhou D, Abutarif M, Garimella T

24.09.25

An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design

PBPK & PBBM

Trial design and analysis

Methodology

CPT Pharmacometrics Syst Pharmacol. 2025 Sep 24. Online ahead of print.

Hamadeh A, Pellowe M, Chelle P, Yeung CHT, Otalvaro J, Yamada W, Bartroff J, Kryshchenko A, Dallmann A, Solodenko J, Lippert J, Tsakalozou E, Neely M, Edginton A.

16.09.25

Rock and roll – deliverables driven by standardized data specifications [1]

Program strategies and efficiencies

Automation

PHUSE EU Connect 2025, Poster PP25.

Sandström E, Hellner J, Ette G, Gaby A, Freiberga S, Prusis P, Suddapalli M

30.07.25

Pharmacometrics education for all by overcoming language barriers to enhance global collaboration

Pharmacometrics

J Pharmacokinet Pharmacodyn. 2025 Jul 30;52(4):46.

Khier S, Chan Kwong AHP, Harnichard M, Ait-Oudhia S

15.06.25

The dawn of a new era: can machine learning and large language models reshape QSP modeling?

QSP

Automation

Methodology

J Pharmacokinet Pharmacodyn. 2025 Jun 16;52(4):36.

Androulakis IP, Cucurull-Sanchez L, Kondic A, Mehta K, Pichardo C, Pryor M, Renardy M

03.06.25

Physiologically based predictions of monoclonal antibody pharmacokinetics: insights from a large-scale data analysis

PBPK & PBBM

Program strategies and efficiencies

PAGE 33 (2025) Abstr 11791

Benamara S, Sjögren E, Gattacceca F, Chenel M, Deslandes A, Nguyen L, Teutonico D

03.06.25

Development of efficient CAR-T cell clinical study designs: Towards understanding of novel anticancer therapies through optimal experimental design

Oncology

Trial design and analysis

Pharmacometrics

Methodology

PAGE 33 (2025) Abstr 11783

Klima F, Mc Laughlin AM, Michelet R, Winkler A, Huisinga W, Haussmann K, Künkele A, Hooker AC, Kloft C.

03.06.25

Application of model-informed drug development for dose optimization of brigimadlin in patients with dedifferentiated liposarcoma

Phase I

Phase II

Phase III

Oncology

MIDD

Trial design and analysis

Pharmacometrics

Program strategies and efficiencies

PAGE 33 (2025) Abstr 11666

Zdovc JA, Gausi K, Langenhorst J, Yin A, Acharya C, Sarr C, Friberg LE, Lahmar M, Grempler R, Pérez-Pitarch A, Schmid U, LoRusso P, Sailer R, Busse D.

Search publications

Publications

Related content

Science & Services

Latest news

People & Culture